DMCC Speciality Chemicals Ltd

- No significant new large investments or expansions planned in the near term due to current market uncertainty and high interest rates. - The company is focused on generating operating cash flow and paying down existing loans rather than raising new debt. - They will wait for interest rates to come down before considering aggressive fundraising or expansion. - No specific mention of any upcoming equity fundraising in the transcript. - Capital expenditure for FY24 and FY25 is expected to be modest and significantly lower than in the last two years. - Overall, the approach is cautious with no immediate plans for major debt or equity fundraising.

- No major large investments planned currently due to market uncertainty and high interest rates; focus is on paying down loans and maintaining prudence. - Future aggressive investments depend on improved operating cash flow and easing interest rates. - No significant CAPEX expected for FY24 and FY25 compared to the last two years. - Investments will likely be made in both CAPEX and people, especially for R&D and innovation to advance science and support global innovators. - The company has completed most of its large capital expenditure for the foreseeable future and achieved desired production levels and efficiencies. - Additional sustainability-related projects are underway, including one due this year to substantially reduce carbon footprint. - Potential investments to increase boron business are considered but not ready for initiation yet.

- Growth seen across existing and new speciality chemical products, reflecting broad traction (Page 5). - Exports grew 61% in FY23 over FY22; volume growth likely at least 60%, though exact figures are not specified (Page 4). - Future volume growth difficult to predict due to macroeconomic headwinds and market uncertainties, especially global slowdown and Europe crisis (Pages 4, 5, 9). - Domestic and export markets are interconnected; growth depends on global trends and customer demand (Page 5). - Current market described as soft with low consumer demand and excess production, delaying optimism in sales recovery (Page 9). - Potential increase of 30-40% in downstream product volumes at expanded facilities (Page 8). - Improvements expected in boron business supply and production rate, supporting incremental growth (Page 8). - Overall, growth prospects are cautiously optimistic but subject to external uncertainties and market conditions (Pages 4, 8, 9).

- Company aims for bigger top line and bottom line; actively working towards growth and sustainability improvement (Page 12). - No specific forward-looking earnings or EPS guidance provided due to market uncertainties and macro headwinds (Page 4, 12). - Expectation of improved volumes, particularly in downstream and speciality chemicals segments after recent expansions (Pages 6, 10). - Export growth seen at 61% in FY23; volume growth likely above 60%, but exact future projections avoided (Page 4, 5). - Margins could improve on lower raw material prices but absolute margin predictions are avoided (Page 8). - Current CAPEX limited with cautious approach amid high interest rates and uncertain environment (Pages 8, 12). - Growth dependent on recovery of industrial demand and easing interest rates; no specific profit or EPS targets shared (Pages 10, 12).

Based on the transcript from page 12 of the DMCC Q4FY23 conference call: - No specific mention of current or expected order book size or pending orders was provided. - Bimal L Goculdas emphasized market uncertainties and challenges affecting demand and growth. - The company experienced slow customer buying due to global economic conditions, crises in Europe, and interest rate cycles. - Investment plans, including expansions and CAPEX, are being held back until better market visibility and improved consumer sentiment. - There is cautious optimism about future demand once interest rates ease and global markets stabilize. - Overall, DMCC is focused on maintaining production levels with flexibility until clearer demand signals emerge. No explicit quantitative data on order book or pending orders was disclosed in the provided transcript.